Key result
Preoperative levosimendan administration in 18 patients with LVEF ≤35% undergoing CABG was well tolerated and resulted in 0% in-hospital mortality.
No takes yet. Share an insight, caveat, or question.
Preoperative levosimendan administration may improve haemodynamic function and clinical outcomes in patients with poor left ventricular function undergoing CABG.
Yavuz et al. (2013) conducted a letter in Coronary artery bypass grafting with LVEF ≤35% (n=18). Preoperative levosimendan was evaluated on In-hospital mortality. Preoperative levosimendan administration in 18 patients with LVEF ≤35% undergoing CABG was well tolerated and resulted in 0% in-hospital mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: